Is the Packaging Supply Chain Ready?
Pharmaceutical Technology Europe
; 32(12):34-36, 2020.
Artículo
en Inglés
| ProQuest Central | ID: covidwho-20235618
ABSTRACT
[...]SCHOTT, which operates a global validated production network with 20 plants and more than 600 production lines for pharma glass and packaging, already has delivered millions of glass vials to SARS-CoV-2 programmes including supplying three out of every four COVID-19 vaccine projects undergoing Phase I, II, and III testing (3). Since we produce the pharmaceutical glass tubing for the packaging ourselves, we are also able to adjust the capacities for glass production in advance, which also benefits packaging manufacturers who do not have their own glass production facilities." "Since our sites are already validated by the authorities and by major pharma companies, our expansion is happening at a very fast pace," reports Stöcker. Per the agreement ... with BARDA [Biomedical Advanced Research and Development Authority, part of the US Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response], Corning will provide priority access to designated BARDA vaccine and drug development partners."
Pharmacy And Pharmacology; Marketing; COVID-19 vaccines; Shortages; Severe acute respiratory syndrome coronavirus 2; Pandemics; Life sciences; Pharmaceutical industry; Supply chains; ISO standards; Automation; Manufacturing; Packaging; Coronaviruses; Suppliers; Preservatives; Drug dosages; United States--US; 42384:Industrial Supplies Merchant Wholesalers; 42421:Drugs and Druggists' Sundries Merchant Wholesalers; 32541:Pharmaceutical and Medicine Manufacturing
Buscar en Google
Colección:
Bases de datos de organismos internacionales
Base de datos:
ProQuest Central
Tipo de estudio:
Estudio pronóstico
Tópicos:
Vacunas
Idioma:
Inglés
Revista:
Pharmaceutical Technology Europe
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS